跳至主要内容
临床试验/NCT01857492
NCT01857492撤回不适用

tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家开始时间: 2013年3月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Pain

研究概览

简要总结

This study is testing whether the addition of a noninvasive form of brain stimulation called transcranial direct current stimulation (tDCS) when combined with meditation helps decrease the abdominal pain in patients with chronic pancreatitis. The device involved in this study, transcranial direct current stimulation (tDCS) is investigational. This means that the study device is still being tested in research studies and is not approved by the Food and Drug Administration [FDA].

详细描述

This is a double-blind, pilot study with the goal of testing the effects of tDCS coupled with meditation in the management of visceral pain in patients with chronic pancreatitis. We will enroll a total of 14 subjects with chronic pancreatitis. After enrollment, subjects will be randomized to active stimulation plus mediation (7 subjects) or sham stimulation plus meditation (7 subjects). Subjects will undergo 5 days of active tDCS stimulation plus meditation or sham tDCS plus meditation. Sessions will last approximately 30 min - 1 hour. EEG activity will be measured in the first, last and follow-up visits. After each stimulation session, we will assess for adverse effects using the tDCS adverse effects questionnaire. We will also have the subject fill out a pain/medication diary during the 5 days of treatment. All study procedures will be completed at BIDMC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provide informed consent to participate in the study
  • 18 years old
  • If taking pain medications, stable doses are required for at least 1 month prior to initiation of the study

排除标准

  • History of alcohol or substance abuse within the last 6 months as self-reported
  • Suffering from severe depression (with a score of >30 in the Beck Depression Inventory)
  • Diagnosis of any neurological diseases (such as epilepsy)
  • Episodes of seizures within the last 6 months
  • Unexplained loss of consciousness
  • Use of carbamazepine or neuropsychotropic drugs
  • Have had no neurosurgery as self reported
  • Contraindications to tDCS
  • Metal in the head
  • Implanted brain medical devices
  • Pregnant at time of enrollment
  • Previous experience with meditation

结局指标

主要结局

Pain

时间窗: Two weeks

Assess the effects of 5 days of active vs sham tDCS stimulation plus meditation on chronic visceral pain in patients with chronic pancreatitis. We will determine the magnitude of pain reduction using the Visual Analog Scale (VAS) score and Brief Pain Inventory (BPI). We hypothesize that active tDCS plus meditation will have a greater decrease in VAS scores and BPI scores when compared to sham tDCS plus meditation in subjects with chronic pancreatitis

次要结局

  • Quality of Life(Two weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven Freedman

MD PhD Professor of Medicine Harvard Medical School

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验